Making cell therapy accessible: challenges and opportunities

Abstract

Despite major advances in bringing cancer cell therapies to the clinic, their widespread accessibility remains a substantial challenge. High manufacturing costs, lack of funding and varying regulatory standards have restricted patient access. As the field advances, researchers, clinicians, regulatory bodies, funding agencies and industry will need to work together to overcome these barriers. A group of experts share their insights into the most pressing challenges and promising strategies to make cell therapies more broadly accessible.